Mary C Cambou, Christine M Liu, Thalia Mok, Viviana Fajardo-Martinez, Sophia G Paiola, Francisco J Ibarrondo, Tara Kerin, Trevon Fuller, Nicole H Tobin, Gustavo Garcia, Debika Bhattacharya, Grace M Aldrovandi, Vaithilingaraja Arumugaswami, Suan Sin Foo, Jae U Jung, Zilton Vasconcelos, Patricia Brasil, Michelle Brendolin, Otto Yang, Rashmi Rao, Karin Nielsen-Saines
BACKGROUND: There are limited data on how COVID-19 severity, timing of infection, and subsequent vaccination impact transplacental transfer and persistence of maternal and infant antibodies. METHODS: In a longitudinal cohort of pregnant women with PCR-confirmed SARS-CoV-2 infection, maternal/infant sera were collected at enrollment, delivery/birth, and 6 months. Anti-SARS-CoV-2 spike IgG, IgM and IgA were measured by ELISA. RESULTS: 256 pregnant women and 135 infants were enrolled; 148 maternal and 122 neonatal specimens were collected at delivery/birth; 45 maternal and 48 infant specimens were collected at 6 months...
September 9, 2022: Journal of Infectious Diseases